logo
episode-header-image
Oct 2024
23m 58s

Hot shot: the wider promise of weight-lo...

The Economist
About this episode

First they treated diabetes. Then obesity. Now GLP-1 drugs are being tested on a range of other diseases too. Though the US economy is roaring, many Americans are glum about its prospects. How could that affect the election (9:02)? And our podcast on why Chinese migrants are making perilous journeys through the jungle to reach America (16:55).


Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+


For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account. 



Up next
Yesterday
Sprawl of duty: Trump’s tariff drama
Once again President Donald Trump extended the deadline for spine-stiffening tariffs to go into effect on trading partners. We look at the effects of all the uncertainty. Brazil once dominated the world of football; we ask where it went wrong and assess the route to a comeback. A ... Show More
21m 53s
Jul 8
The French reconnection: Macron in Britain
Anglo-French relations have not been so good since before the Brexit vote. Beneath the state-visit pageantry, though, there is much co-operation for President Emmanuel Macron and Prime Minister Keir Starmer to discuss. Gangs have infiltrated many of Latin America’s mining operati ... Show More
21m 10s
Jul 7
Trump card: can he broker a Gaza deal?
While Israel and Hamas officials discuss a ceasefire via mediators in Qatar, a key meeting will take place at the White House today, when Israel’s prime minister talks to the US president. Why the Chinese Communist Party is removing alcohol from official events. And remembering J ... Show More
21m 7s
Recommended Episodes
Aug 2024
The chips are down: will diet drugs devour junk food?
Snack-food companies have long shown their adaptability to changing diets. How could the rise of appetite-suppressing drugs and fears about ultra-processed foods change the food we consume? How hearing aids and other lifestyle choices can reduce your risk of dementia (11:00). And ... Show More
22m 30s
Apr 2024
Money Talks: Why weight-loss drugs will reshape the world
More than 1bn people around the world are obese. That means there should be extraordinary demand for drugs to cure or mitigate the condition. Novo Nordisk is now Europe’s most valuable company and Eli Lilly’s market value has more than doubled. Both make the “miracle” drugs that ... Show More
36m 59s
Feb 2025
Chinese Biotech Is Having A DeepSeek Moment
P.M. Edition for Feb. 7. China’s biotech industry is creating new drugs more cheaply and quickly than its U.S. counterparts. WSJ Heard on the Street columnist David Wainer tells us what’s behind the sector’s rise. Plus, new data show the U.S. economy added fewer jobs than expecte ... Show More
13m 48s
Dec 2024
A checkup on weight-loss drugs
What started as a story about Hollywood waistlines has become a global phenomenon. Weight loss drugs are becoming more and more mainstream a few years after making their dramatic debut. On this weekend episode of Reuters World News, our health reporters weigh in on the impact of ... Show More
20m 17s
Apr 7
Doomed traders: Trump’s tariff fallout
Since Donald Trump announced punishing tariffs on “Liberation Day” last week, stock markets have fallen and governments and businesses scrambled to respond. Our correspondent discusses the impact on the global economy. Do personalised diets really improve gut health (9:16)? And g ... Show More
21m 20s
Jun 25
Stayed in China: a domestic-brand boom
Western brands used to define cool and luxurious in China. No longer. Now consumers are turning to homegrown brands, some of which are becoming global tastemakers. Across Africa the Christian conservative movement is gaining ground fast—with a little help from American brethren. ... Show More
22m 54s
Jan 2025
Putty people: can Trump get his picks?
As some of Donald Trump’s most controversial choices for top jobs are questioned this week, our correspondent analyses how supine Republicans may be in his second term. Has the luxury business passed its peak (09:57)? And why scientists are finding new ways to deal with an invasi ... Show More
23m 20s
Dec 2024
Country of the year: The Economist picks
In the past 12 months, there has been no lack of news. Editors at The Economist have picked their way through the rubble to uncover some optimism: which country has seen the greatest improvement this year? After fierce debate, the decision is conclusive. And our correspondent joi ... Show More
27m 53s
May 15
Drug war: Trump takes on big pharma
Drugs in America often cost more than three times as much as those elsewhere. But Donald Trump’s plan to cut prescription costs and impose tariffs may have unintended consequences for consumers. Inside North Korea’s crypto-heist: from hermit kingdom to hacking kingdom (10:45). An ... Show More
25m 6s
Mar 2025
Population Collapse is a Massive Problem - Dr Paul Morland
Dr Paul Morland is an author and broadcaster who writes and speaks about population and the big demographic trends across the world, both contemporary and historic. | SPONSOR. We use Ground News to escape the echo chamber and stay fully informed. Go to https://ground.news/trigger ... Show More
1h 21m